Skip to main content
Fig. 7 | BMC Complementary Medicine and Therapies

Fig. 7

From: An in vitro study elucidating the synergistic effects of aqueous cinnamon extract and an anti-TNF-α biotherapeutic: implications for a complementary and alternative therapy for non-responders

Fig. 7

High (50 µg/mL) and low (25 µg/mL) concentrations of C. cassia aCE (A (L929) and B (U937)) and high (40 µg/mL) and low (32 µg/mL) concentrations TCA (C (L929) and D (U937)) downregulated the mRNA levels of ICAM-1 and VCAM-1 synergistically with infliximab. C. zeylanicum aCE did not show any effect on the expression of the selected mRNAs (E (L929) and F (U937))

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us